Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	210 mg	40
Overall Study	STARTED	140 mg	39
Overall Study	STARTED	280 mg	42
Overall Study	STARTED	Placebo	38
Overall Study	STARTED	70 mg	39
Overall Study	COMPLETED	210 mg	37
Overall Study	COMPLETED	140 mg	38
Overall Study	COMPLETED	280 mg	40
Overall Study	COMPLETED	Placebo	32
Overall Study	COMPLETED	70 mg	37
Overall Study	NOT COMPLETED	210 mg	3
Overall Study	NOT COMPLETED	140 mg	1
Overall Study	NOT COMPLETED	280 mg	2
Overall Study	NOT COMPLETED	Placebo	6
Overall Study	NOT COMPLETED	70 mg	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00975637/flow